Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Drugs during pregnancy and lactation [[electronic resource] ] : handbook of prescription drugs and comparative risk assessment : with updated information on recreational drugs, diagnostic procedures, vaccinations, poisoning, workplace and environmental contaminants, and breastfeeding during infectious disease / / edited by Christof Schaefer
| Drugs during pregnancy and lactation [[electronic resource] ] : handbook of prescription drugs and comparative risk assessment : with updated information on recreational drugs, diagnostic procedures, vaccinations, poisoning, workplace and environmental contaminants, and breastfeeding during infectious disease / / edited by Christof Schaefer |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Amsterdam ; ; New York, : Elsevier, 2007 |
| Descrizione fisica | 1 online resource (907 p.) |
| Disciplina | 618.32 |
| Altri autori (Persone) | SchaeferChristof |
| Soggetto topico |
Pregnant women - Drug use
Pregnant women - Medical care Obstetrical pharmacology Fetus - Effect of drugs on Newborn infants - Effect of drugs on |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-01913-5
9786611019136 0-08-054977-2 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front cover; Drugs During Pregnancy and Lactation, Second edition; Copyright page; Contents; List of contributors; Preface; Notice; Chapter 1 General commentary on drug therapy and drug risks in pregnancy; 1.1 Introduction; 1.2 Development and health; 1.3 Reproductive stages; 1.4 Reproductive and developmental toxicology; 1.5 Basic principles of drug-induced reproductive and developmental toxicology; 1.6 Effects and manifestations; 1.7 Pharmacokinetics in pregnancy; 1.8 Passage of drugs to the unborn and fetal kinetics; 1.9 Causes of developmental disorders
1.10 Embryo/fetotoxic risk assessment1.11 Classification of drugs used in pregnancy; 1.12 Paternal use of medicinal products; 1.13 Communicating the risk of drug use in pregnancy; 1.14 Risk communication prior to pharmacotherapeutic choice; 1.15 Risk communication regarding the safety (or otherwise) of drugs already used in pregnancy; 1.16 Teratology information centers; Chapter 2 Specific drug therapies during pregnancy; 2.1 Analgesics and anti-inflammatory drugs; 2.1.1 Paracetamol (acetaminophen); 2.1.2 Aspirin (acetylsalicylic acid); 2.1.3 Pyrazolone derivatives 2.1.4 Combination analgesic preparations2.1.5 Opioid analgesics in general; 2.1.6 Morphine; 2.1.7 Codeine; 2.1.8 Pethidine (meperidine); 2.1.9 Fentanyl, alfentanil, remifentanil, and sufentanil; 2.1.10 Other narco-analgesics and centrally acting analgesics; 2.1.11 Naloxone; 2.1.12 Nonsteroidal anti-inflammatory drugs (NSAIDs); 2.1.13 Selective cyclooxygenase-2 (COX-2) inhibitors; 2.1.14 Migraine medications; 2.1.15 Additional analgesics; 2.1.16 Additional antiphlogistics and antirheumatics; 2.1.17 Myotonolytics; 2.1.18 Gout interval therapy; 2.1.19 Gout attack therapy 2.2 Antiallergic drugs and desensitization2.2.1 Antihistamines (H[sub(1)]-blocker); 2.2.2 Glucocorticosteroids; 2.2.3 Mast cell stabilizers; 2.2.4 Immunotherapy; 2.3 Antiasthmatic and cough medication; 2.3.1 Asthma and pregnancy; 2.3.2 Selective β[sub(2)]-adrenergic agonists; 2.3.3 Corticosteroids; 2.3.4 Anticholinergic drugs; 2.3.5 Theophylline; 2.3.6 Cromoglycate, nedocromil, and lodoxamide; 2.3.7 Other mast cell inhibitors; 2.3.8 Antileukotrienes; 2.3.9 Monoclonal antibodies and other asthma medications; 2.3.10 Expectorants and mucolytic agents; 2.3.11 Antitussives 2.3.12 Non-selective β-adrenergic agonists2.4 Antiemetics; 2.4.1 Nausea and vomiting in pregnancy; 2.4.2 Diet manipulations and treatment; 2.4.3 Complementary treatment options; 2.4.4 Acupuncture and acupressure; 2.4.5 Hypnosis; 2.4.6 Ginger; 2.4.7 Antihistamines (H[sub(1)]-blockers); 2.4.8 Dopamine antagonists; 2.4.9 Pyridoxine (vitamin B[sub(6)]); 2.4.10 Thiamine (vitamin B[sub(1)]); 2.4.11 Serotonin antagonists; 2.4.12 Glucocorticoids; 2.4.13 Other agents with antiemetic properties; 2.5 Gastrointestinal and antilipidemic agents and spasmolytics 2.5.1 Gastritis and peptic ulcer during pregnancy |
| Record Nr. | UNINA-9910458841103321 |
| Amsterdam ; ; New York, : Elsevier, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drugs during pregnancy and lactation [[electronic resource] ] : handbook of prescription drugs and comparative risk assessment : with updated information on recreational drugs, diagnostic procedures, vaccinations, poisoning, workplace and environmental contaminants, and breastfeeding during infectious disease / / edited by Christof Schaefer
| Drugs during pregnancy and lactation [[electronic resource] ] : handbook of prescription drugs and comparative risk assessment : with updated information on recreational drugs, diagnostic procedures, vaccinations, poisoning, workplace and environmental contaminants, and breastfeeding during infectious disease / / edited by Christof Schaefer |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Amsterdam ; ; New York, : Elsevier, 2007 |
| Descrizione fisica | 1 online resource (907 p.) |
| Disciplina | 618.32 |
| Altri autori (Persone) | SchaeferChristof |
| Soggetto topico |
Pregnant women - Drug use
Pregnant women - Medical care Obstetrical pharmacology Fetus - Effect of drugs on Newborn infants - Effect of drugs on |
| ISBN | 9780080549774 (Electronic Book) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front cover; Drugs During Pregnancy and Lactation, Second edition; Copyright page; Contents; List of contributors; Preface; Notice; Chapter 1 General commentary on drug therapy and drug risks in pregnancy; 1.1 Introduction; 1.2 Development and health; 1.3 Reproductive stages; 1.4 Reproductive and developmental toxicology; 1.5 Basic principles of drug-induced reproductive and developmental toxicology; 1.6 Effects and manifestations; 1.7 Pharmacokinetics in pregnancy; 1.8 Passage of drugs to the unborn and fetal kinetics; 1.9 Causes of developmental disorders
1.10 Embryo/fetotoxic risk assessment1.11 Classification of drugs used in pregnancy; 1.12 Paternal use of medicinal products; 1.13 Communicating the risk of drug use in pregnancy; 1.14 Risk communication prior to pharmacotherapeutic choice; 1.15 Risk communication regarding the safety (or otherwise) of drugs already used in pregnancy; 1.16 Teratology information centers; Chapter 2 Specific drug therapies during pregnancy; 2.1 Analgesics and anti-inflammatory drugs; 2.1.1 Paracetamol (acetaminophen); 2.1.2 Aspirin (acetylsalicylic acid); 2.1.3 Pyrazolone derivatives 2.1.4 Combination analgesic preparations2.1.5 Opioid analgesics in general; 2.1.6 Morphine; 2.1.7 Codeine; 2.1.8 Pethidine (meperidine); 2.1.9 Fentanyl, alfentanil, remifentanil, and sufentanil; 2.1.10 Other narco-analgesics and centrally acting analgesics; 2.1.11 Naloxone; 2.1.12 Nonsteroidal anti-inflammatory drugs (NSAIDs); 2.1.13 Selective cyclooxygenase-2 (COX-2) inhibitors; 2.1.14 Migraine medications; 2.1.15 Additional analgesics; 2.1.16 Additional antiphlogistics and antirheumatics; 2.1.17 Myotonolytics; 2.1.18 Gout interval therapy; 2.1.19 Gout attack therapy 2.2 Antiallergic drugs and desensitization2.2.1 Antihistamines (H[sub(1)]-blocker); 2.2.2 Glucocorticosteroids; 2.2.3 Mast cell stabilizers; 2.2.4 Immunotherapy; 2.3 Antiasthmatic and cough medication; 2.3.1 Asthma and pregnancy; 2.3.2 Selective β[sub(2)]-adrenergic agonists; 2.3.3 Corticosteroids; 2.3.4 Anticholinergic drugs; 2.3.5 Theophylline; 2.3.6 Cromoglycate, nedocromil, and lodoxamide; 2.3.7 Other mast cell inhibitors; 2.3.8 Antileukotrienes; 2.3.9 Monoclonal antibodies and other asthma medications; 2.3.10 Expectorants and mucolytic agents; 2.3.11 Antitussives 2.3.12 Non-selective β-adrenergic agonists2.4 Antiemetics; 2.4.1 Nausea and vomiting in pregnancy; 2.4.2 Diet manipulations and treatment; 2.4.3 Complementary treatment options; 2.4.4 Acupuncture and acupressure; 2.4.5 Hypnosis; 2.4.6 Ginger; 2.4.7 Antihistamines (H[sub(1)]-blockers); 2.4.8 Dopamine antagonists; 2.4.9 Pyridoxine (vitamin B[sub(6)]); 2.4.10 Thiamine (vitamin B[sub(1)]); 2.4.11 Serotonin antagonists; 2.4.12 Glucocorticoids; 2.4.13 Other agents with antiemetic properties; 2.5 Gastrointestinal and antilipidemic agents and spasmolytics 2.5.1 Gastritis and peptic ulcer during pregnancy |
| Record Nr. | UNINA-9910784615103321 |
| Amsterdam ; ; New York, : Elsevier, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drugs during pregnancy and lactation : handbook of prescription drugs and comparative risk assessment : with updated information on recreational drugs, diagnostic procedures, vaccinations, poisoning, workplace and environmental contaminants, and breastfeeding during infectious disease / / edited by Christof Schaefer
| Drugs during pregnancy and lactation : handbook of prescription drugs and comparative risk assessment : with updated information on recreational drugs, diagnostic procedures, vaccinations, poisoning, workplace and environmental contaminants, and breastfeeding during infectious disease / / edited by Christof Schaefer |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Amsterdam ; ; New York, : Elsevier, 2007 |
| Descrizione fisica | 1 online resource (907 p.) |
| Disciplina | 618.32 |
| Altri autori (Persone) | SchaeferChristof |
| Soggetto topico |
Pregnant women - Drug use
Pregnant women - Medical care Obstetrical pharmacology Fetus - Effect of drugs on Newborn infants - Effect of drugs on |
| ISBN | 9780080549774 (Electronic Book) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front cover; Drugs During Pregnancy and Lactation, Second edition; Copyright page; Contents; List of contributors; Preface; Notice; Chapter 1 General commentary on drug therapy and drug risks in pregnancy; 1.1 Introduction; 1.2 Development and health; 1.3 Reproductive stages; 1.4 Reproductive and developmental toxicology; 1.5 Basic principles of drug-induced reproductive and developmental toxicology; 1.6 Effects and manifestations; 1.7 Pharmacokinetics in pregnancy; 1.8 Passage of drugs to the unborn and fetal kinetics; 1.9 Causes of developmental disorders
1.10 Embryo/fetotoxic risk assessment1.11 Classification of drugs used in pregnancy; 1.12 Paternal use of medicinal products; 1.13 Communicating the risk of drug use in pregnancy; 1.14 Risk communication prior to pharmacotherapeutic choice; 1.15 Risk communication regarding the safety (or otherwise) of drugs already used in pregnancy; 1.16 Teratology information centers; Chapter 2 Specific drug therapies during pregnancy; 2.1 Analgesics and anti-inflammatory drugs; 2.1.1 Paracetamol (acetaminophen); 2.1.2 Aspirin (acetylsalicylic acid); 2.1.3 Pyrazolone derivatives 2.1.4 Combination analgesic preparations2.1.5 Opioid analgesics in general; 2.1.6 Morphine; 2.1.7 Codeine; 2.1.8 Pethidine (meperidine); 2.1.9 Fentanyl, alfentanil, remifentanil, and sufentanil; 2.1.10 Other narco-analgesics and centrally acting analgesics; 2.1.11 Naloxone; 2.1.12 Nonsteroidal anti-inflammatory drugs (NSAIDs); 2.1.13 Selective cyclooxygenase-2 (COX-2) inhibitors; 2.1.14 Migraine medications; 2.1.15 Additional analgesics; 2.1.16 Additional antiphlogistics and antirheumatics; 2.1.17 Myotonolytics; 2.1.18 Gout interval therapy; 2.1.19 Gout attack therapy 2.2 Antiallergic drugs and desensitization2.2.1 Antihistamines (H[sub(1)]-blocker); 2.2.2 Glucocorticosteroids; 2.2.3 Mast cell stabilizers; 2.2.4 Immunotherapy; 2.3 Antiasthmatic and cough medication; 2.3.1 Asthma and pregnancy; 2.3.2 Selective β[sub(2)]-adrenergic agonists; 2.3.3 Corticosteroids; 2.3.4 Anticholinergic drugs; 2.3.5 Theophylline; 2.3.6 Cromoglycate, nedocromil, and lodoxamide; 2.3.7 Other mast cell inhibitors; 2.3.8 Antileukotrienes; 2.3.9 Monoclonal antibodies and other asthma medications; 2.3.10 Expectorants and mucolytic agents; 2.3.11 Antitussives 2.3.12 Non-selective β-adrenergic agonists2.4 Antiemetics; 2.4.1 Nausea and vomiting in pregnancy; 2.4.2 Diet manipulations and treatment; 2.4.3 Complementary treatment options; 2.4.4 Acupuncture and acupressure; 2.4.5 Hypnosis; 2.4.6 Ginger; 2.4.7 Antihistamines (H[sub(1)]-blockers); 2.4.8 Dopamine antagonists; 2.4.9 Pyridoxine (vitamin B[sub(6)]); 2.4.10 Thiamine (vitamin B[sub(1)]); 2.4.11 Serotonin antagonists; 2.4.12 Glucocorticoids; 2.4.13 Other agents with antiemetic properties; 2.5 Gastrointestinal and antilipidemic agents and spasmolytics 2.5.1 Gastritis and peptic ulcer during pregnancy |
| Record Nr. | UNINA-9910828812503321 |
| Amsterdam ; ; New York, : Elsevier, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drugs for pregnant and lactating women / / Carl P. Weiner, Clifford Mason
| Drugs for pregnant and lactating women / / Carl P. Weiner, Clifford Mason |
| Autore | Weiner Carl P. |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Philadelphia, PA : , : Elsevier, , [2019] |
| Descrizione fisica | 1 online resource (1,027 pages) |
| Disciplina | 618.3/2 |
| Soggetto topico |
Pregnancy - Effect of drugs on
Breastfeeding - Effect of drugs on Fetus - Effect of drugs on Newborn infants - Effect of drugs on Obstetrical pharmacology Drugs - Side effects Pregnancy - drug effects Breast Feeding - adverse effects Contraindications Drug-Related Side Effects and Adverse Reactions Fetus - drug effects Pharmaceutical Preparations Pregnancy Complications - chemically induced Infant |
| Soggetto genere / forma | Handbook |
| ISBN | 0-323-50870-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910583310803321 |
Weiner Carl P.
|
||
| Philadelphia, PA : , : Elsevier, , [2019] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Farmacologie voor vroedvrouwen : leidraad voor opleiding en dagelijkse praktijk / / Dr. G. Faron, Dr. D. Bayot
| Farmacologie voor vroedvrouwen : leidraad voor opleiding en dagelijkse praktijk / / Dr. G. Faron, Dr. D. Bayot |
| Autore | Faron G. |
| Edizione | [Tweede editie.] |
| Pubbl/distr/stampa | Brussels, Belgium : , : Academic and Scientific Publishers, , 2015 |
| Descrizione fisica | 1 online resource (224 pages) |
| Disciplina | 618.2061 |
| Soggetto topico | Obstetrical pharmacology |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | dut |
| Record Nr. | UNINA-9910792901003321 |
|
Faron G.
|
||
| Brussels, Belgium : , : Academic and Scientific Publishers, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Farmacologie voor vroedvrouwen : leidraad voor opleiding en dagelijkse praktijk / / Dr. G. Faron, Dr. D. Bayot
| Farmacologie voor vroedvrouwen : leidraad voor opleiding en dagelijkse praktijk / / Dr. G. Faron, Dr. D. Bayot |
| Autore | Faron G. |
| Edizione | [Tweede editie.] |
| Pubbl/distr/stampa | Brussels, Belgium : , : Academic and Scientific Publishers, , 2015 |
| Descrizione fisica | 1 online resource (224 pages) |
| Disciplina | 618.2061 |
| Soggetto topico | Obstetrical pharmacology |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | dut |
| Record Nr. | UNINA-9910812857903321 |
|
Faron G.
|
||
| Brussels, Belgium : , : Academic and Scientific Publishers, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Klinische Prüfungen mit Arzneimitteln in der Schwangerschaft / / Sonja Knop
| Klinische Prüfungen mit Arzneimitteln in der Schwangerschaft / / Sonja Knop |
| Autore | Knop Sonja |
| Pubbl/distr/stampa | Universitätsverlag Göttingen, 2015 |
| Descrizione fisica | 1 online resource (xi, 359 pages) : digital, PDF file(s) |
| Disciplina | 615.580724 |
| Collana |
Open Access e-Books
Knowledge Unlatched Göttinger Schriften zum Medizinrecht |
| Soggetto topico |
Clinical trials
Obstetrical pharmacology Drugs - Law and legislation - Germany |
| Soggetto non controllato |
pregnancy
clinical trials pharmaceuticals Arzneimittel Fötus Grundgesetz für die Bundesrepublik Deutschland Klinische Studie Nasciturus (Deutschland) Schwangerschaft |
| ISBN | 9783863952334 (ebook) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ger |
| Record Nr. | UNINA-9910137035103321 |
|
Knop Sonja
|
||
| Universitätsverlag Göttingen, 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neonatal formulary 5 [[electronic resource] ] : drug use in pregnancy and the first year of life / / [compiled and edited by Edmund Hey]
| Neonatal formulary 5 [[electronic resource] ] : drug use in pregnancy and the first year of life / / [compiled and edited by Edmund Hey] |
| Edizione | [5th ed.] |
| Pubbl/distr/stampa | Malden, MA ; ; Oxford, : Blackwell Pub., 2007 |
| Descrizione fisica | 1 online resource (322 p.) |
| Disciplina | 615.13 |
| Altri autori (Persone) | HeyEdmund |
| Soggetto topico |
Newborn infants - Effect of drugs on
Pharmacopoeias Obstetrical pharmacology |
| ISBN |
1-281-32214-8
9786611322144 0-470-75087-1 0-470-75035-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Neonatal Formulary 5: Drug Use in Pregnancy and the First Year of Life; Contents; Introduction; Important advisory statement; Further reading; Part 1 Drug prescribing and drug administration; Terms, symbols, abbreviations and units; Drug storage; Neonatal drug administration; Drugs and the body; Drugs and the law; Care and use of intravascular lines; Minimising IV infusion and drug hazards; Writing a hospital prescription; Adverse reactions and overtreatment; Renal failure; Body weight and surface area; Useful website addresses; Part 2 Drug Monographs
Part 3 Maternal medication and its effect on the babyIntroduction; Further reading; Maternal medication and the baby; Index, including synonyms and abbreviations |
| Record Nr. | UNINA-9910784809703321 |
| Malden, MA ; ; Oxford, : Blackwell Pub., 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neonatal formulary 5 [[electronic resource] ] : drug use in pregnancy and the first year of life / / [compiled and edited by Edmund Hey]
| Neonatal formulary 5 [[electronic resource] ] : drug use in pregnancy and the first year of life / / [compiled and edited by Edmund Hey] |
| Edizione | [5th ed.] |
| Pubbl/distr/stampa | Malden, MA ; ; Oxford, : Blackwell Pub., 2007 |
| Descrizione fisica | 1 online resource (322 p.) |
| Disciplina | 615.13 |
| Altri autori (Persone) | HeyEdmund |
| Soggetto topico |
Newborn infants - Effect of drugs on
Pharmacopoeias Obstetrical pharmacology |
| ISBN |
1-281-32214-8
9786611322144 0-470-75087-1 0-470-75035-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Neonatal Formulary 5: Drug Use in Pregnancy and the First Year of Life; Contents; Introduction; Important advisory statement; Further reading; Part 1 Drug prescribing and drug administration; Terms, symbols, abbreviations and units; Drug storage; Neonatal drug administration; Drugs and the body; Drugs and the law; Care and use of intravascular lines; Minimising IV infusion and drug hazards; Writing a hospital prescription; Adverse reactions and overtreatment; Renal failure; Body weight and surface area; Useful website addresses; Part 2 Drug Monographs
Part 3 Maternal medication and its effect on the babyIntroduction; Further reading; Maternal medication and the baby; Index, including synonyms and abbreviations |
| Record Nr. | UNISA-996203962503316 |
| Malden, MA ; ; Oxford, : Blackwell Pub., 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Neonatal formulary 5 : drug use in pregnancy and the first year of life / / [compiled and edited by Edmund Hey]
| Neonatal formulary 5 : drug use in pregnancy and the first year of life / / [compiled and edited by Edmund Hey] |
| Edizione | [5th ed.] |
| Pubbl/distr/stampa | Malden, MA ; ; Oxford, : Blackwell Pub., 2007 |
| Descrizione fisica | 1 online resource (322 p.) |
| Disciplina | 615.13 |
| Altri autori (Persone) | HeyEdmund |
| Soggetto topico |
Newborn infants - Effect of drugs on
Pharmacopoeias Obstetrical pharmacology |
| ISBN |
1-281-32214-8
9786611322144 0-470-75087-1 0-470-75035-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Neonatal Formulary 5: Drug Use in Pregnancy and the First Year of Life; Contents; Introduction; Important advisory statement; Further reading; Part 1 Drug prescribing and drug administration; Terms, symbols, abbreviations and units; Drug storage; Neonatal drug administration; Drugs and the body; Drugs and the law; Care and use of intravascular lines; Minimising IV infusion and drug hazards; Writing a hospital prescription; Adverse reactions and overtreatment; Renal failure; Body weight and surface area; Useful website addresses; Part 2 Drug Monographs
Part 3 Maternal medication and its effect on the babyIntroduction; Further reading; Maternal medication and the baby; Index, including synonyms and abbreviations |
| Record Nr. | UNINA-9910816380203321 |
| Malden, MA ; ; Oxford, : Blackwell Pub., 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
